This is a StreetInsider.com Premium Only Page

Celldex (CLDX) – Hot FDA News

Feb 27, 2023 07:38 AM Celldex (CLDX) Climbs 17% Following Positive Data from Barzolvolimab Phase 1b Study

Mar 29, 2021 06:31 AM Celldex (CLDX) Reports 80% Complete Response Rate in Interim Data Update from Phase 1b study of CDX-0159 in Chronic Inducible Urticaria

Apr 16, 2018 07:04 AM

Nov 30, 2017 08:02 AM

Nov 14, 2014 03:38 PM